BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19197956)

  • 1. Robust joint modeling of longitudinal measurements and competing risks failure time data.
    Li N; Elashoff RM; Li G
    Biom J; 2009 Feb; 51(1):19-30. PubMed ID: 19197956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A joint model for longitudinal measurements and survival data in the presence of multiple failure types.
    Elashoff RM; Li G; Li N
    Biometrics; 2008 Sep; 64(3):762-771. PubMed ID: 18162112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data.
    Deslandes E; Chevret S
    BMC Med Res Methodol; 2010 Jul; 10():69. PubMed ID: 20670425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint modeling of longitudinal ordinal data and competing risks survival times and analysis of the NINDS rt-PA stroke trial.
    Li N; Elashoff RM; Li G; Saver J
    Stat Med; 2010 Feb; 29(5):546-57. PubMed ID: 19943331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint modeling and analysis of longitudinal data with informative observation times.
    Liang Y; Lu W; Ying Z
    Biometrics; 2009 Jun; 65(2):377-84. PubMed ID: 18759841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A joint model of longitudinal and competing risks survival data with heterogeneous random effects and outlying longitudinal measurements.
    Huang X; Li G; Elashoff RM
    Stat Interface; 2010; 3(2):185-195. PubMed ID: 21892381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An issue of identifying longitudinal biomarkers for competing risks data with masked causes of failure considering frailties model.
    Ko FS
    Stat Methods Med Res; 2020 Feb; 29(2):603-616. PubMed ID: 30991892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint modeling of survival time and longitudinal outcomes with flexible random effects.
    Choi J; Zeng D; Olshan AF; Cai J
    Lifetime Data Anal; 2018 Jan; 24(1):126-152. PubMed ID: 28856493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-stage approach for joint modeling of longitudinal measurements and competing risks data.
    Mehdizadeh P; Baghfalaki T; Esmailian M; Ganjali M
    J Biopharm Stat; 2021 Jul; 31(4):448-468. PubMed ID: 33905295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint analysis of bivariate longitudinal ordinal outcomes and competing risks survival times with nonparametric distributions for random effects.
    Li N; Elashoff RM; Li G; Tseng CH
    Stat Med; 2012 Jul; 31(16):1707-21. PubMed ID: 22344869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach to joint analysis of longitudinal measurements and competing risks failure time data.
    Elashoff RM; Li G; Li N
    Stat Med; 2007 Jun; 26(14):2813-35. PubMed ID: 17124698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian joint modeling of ordinal longitudinal measurements and competing risks survival data for analysing Tehran Lipid and Glucose Study.
    Baghfalaki T; Kalantari S; Ganjali M; Hadaegh F; Pahlavanzadeh B
    J Biopharm Stat; 2020 Jul; 30(4):689-703. PubMed ID: 32129702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint modeling of survival and longitudinal data: likelihood approach revisited.
    Hsieh F; Tseng YK; Wang JL
    Biometrics; 2006 Dec; 62(4):1037-43. PubMed ID: 17156277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian nonparametric mixed-effects joint model for longitudinal-competing risks data analysis in presence of multiple data features.
    Lu T
    Stat Methods Med Res; 2017 Oct; 26(5):2407-2423. PubMed ID: 26265770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient estimation for patient-specific rates of disease progression using nonnormal linear mixed models.
    Zhang P; Song PX; Qu A; Greene T
    Biometrics; 2008 Mar; 64(1):29-38. PubMed ID: 17501938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilevel latent class models with dirichlet mixing distribution.
    Di CZ; Bandeen-Roche K
    Biometrics; 2011 Mar; 67(1):86-96. PubMed ID: 20560936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating population size for a continuous time frailty model with covariates in a capture-recapture study.
    Xu Y; Liu L; You N; Pan H; Yip P
    Biometrics; 2007 Sep; 63(3):917-21. PubMed ID: 17403102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A semiparametric joint model for longitudinal and survival data with application to hemodialysis study.
    Li L; Hu B; Greene T
    Biometrics; 2009 Sep; 65(3):737-45. PubMed ID: 19173700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint models for a primary endpoint and multiple longitudinal covariate processes.
    Li E; Wang N; Wang NY
    Biometrics; 2007 Dec; 63(4):1068-78. PubMed ID: 17501940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling longitudinal data with nonparametric multiplicative random effects jointly with survival data.
    Ding J; Wang JL
    Biometrics; 2008 Jun; 64(2):546-56. PubMed ID: 17888040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.